BioWorld

Aug. 13, 2003

View Archived Issues

Lilly Drops Out Of One Program With Emisphere, Stays In Another

Emisphere Technologies Inc. lost a partner for one oral hormone replacement therapy but will continue to work in tandem on another oral hormone program. (BioWorld Today) Read More

FDA Rule That Limits Patent Stacking Set To Go Into Effect

Read More

Missing Out On Sunlight, Dietary Calcium, Vitamin D, Some North American Infants Getting Rickets

Read More

QLT Raises $150M In Notes Sale, Plans $50M Buyback Of Stock

Read More

Other News To Note

Read More